Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 343 (LINC00343) is a human gene that encodes a long intergenic non-coding RNA, a subclass of long non-coding RNAs longer than 200 nucleotides that do not overlap with protein-coding genes[5]. LincRNAs such as LINC00343 are primarily involved in fine-tuning the expression of neighboring genes, chromatin remodeling, and regulation of transcription, often in a tissue-specific manner. Although thousands of lincRNAs have been annotated, only a small fraction have been well-characterized, and LINC00343 has no established associations with specific diseases or therapeutic interventions to date[1][5][3]. If you need further functional or disease association data, additional laboratory or high-throughput sequencing studies would be required, as current curated databases list only basic gene annotation without disease or drug relevance[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 343 (LINC00343).